Biotechnology SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Axsome Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 12, 2022 – (NASDAQ: AXSM) June 8, 2022
Biotechnology The Gross Law Firm Announces Class Actions on Behalf of Shareholders of OSCR, AXSM and ET June 7, 2022
Biotechnology Halozyme Announces Commercial Launch of TLANDO(TM), an Oral Treatment for Testosterone Replacement Therapy June 7, 2022
Biotechnology Ascendis Pharma A/S Announces Two Oral Presentations Highlighting the Potential for TransCon(TM) PTH to be a Replacement Therapy for Adult Hypoparathyroidism at ENDO 2022 June 7, 2022
Biotechnology Apellis and Sobi Announce First Patient Dosed in Phase 3 VALIANT Study of Pegcetacoplan for IC-MPGN and C3G, Rare Kidney Diseases with High Unmet Medical Need June 7, 2022
Biotechnology Immatics and Editas Medicine Enter Strategic Research Collaboration and Licensing Agreement to Combine Gamma-Delta T Cell Adoptive Cell Therapies and Gene Editing for the Treatment of Cancer June 7, 2022
Search
Biotechnology
